Conviction: High Status: Researching

2026-07-31 tape note: LITE $713.94 (+9.51% vs $651.93), RSI 45.4 (warmed from 37.5). 7D -6.43% (moderated from -22.16%), 30D -10.89% (moderated from -23.43%), 3M -24.84% (deepened from -24.05%). From the 52-week high, the gap is -34.24% (narrowed from -39.95%). Per the tape: trend "weak-down", regime "pullback", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-07-31 close). 2026-08-08 tape note: LITE $890.17 (+24.68% vs $713.94), RSI 59 (warmed from 45.4). 7D +24.68% (turned positive from -6.43%), 30D +25.89% (turned positive from -10.89%), 3M -1.51% (moderated from -24.84%). From the 52-week high, the gap is -23.89% (narrowed from -34.24%). Per the tape: trend "strong-up", regime "pullback", golden cross intact. News not pulled for this move. Per the full-scan summaries (2026-08-07 close). 2026-08-14 tape note: LITE $926.14 (+4.04% vs $890.17), RSI 58.7 (cooled from 59). 7D +4.04% (moderated from +24.68%), 30D +23.16% (moderated from +25.89%), 3M -4.59% (deepened from -1.51%). From the 52-week high, the gap is -18.91% (narrowed from -23.89%). Per the tape: trend "strong-up", regime "pullback", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-14 close).

---

Editorial Note

Lumentum makes the laser that makes AI possible — and there's no Plan B. LITE controls 50%+ of the global EML laser market, the component inside every 800G and 1.6T optical transceiver connecting AI data centers. NVIDIA committed $2B in non-cancelable orders through end of decade. The Tokyo factory expanded capacity 12x and it's STILL not enough — sold out through 2028. As of 2026-06-16: price $875.36, RSI 47.9 — neutral zone, still below SMA20 ($904.67, -3.2%). The 7D +10.91% bounce is encouraging and shows the stock wants to move; 30D -1.09% suggests the bounce is erasing recent weakness. 3M +34.76% is remarkable and shows the thesis is working on the medium-term frame. Still -19.37% from 52-week high. The monopoly bottleneck thesis remains intact; the current RSI and price setup is better than the May 29 reading (-8.94% 7D, -5.25% 30D) — the stock has found its footing.

2026-07-11 tape check: Price is back down to $802.01, RSI 47.3, back below SMA20 ($828.55, -3.2%) and SMA50 ($887.52, -9.6%). The 7D bounce that carried the June 16 refresh (+10.91%) reversed hard — 30D is now -9.84% and 3M has flipped from +34.76% to -7.94%, and the drawdown from the 52-week high deepened from -19.37% to -26.13%. None of the fundamental story changed (still sold out through 2028, still 50%+ EML share) — this reads as a broad AI-capex-linked derating rather than a thesis break, but the tape has clearly stopped confirming the bull case since June 16 and is now back inside the $750-$850 entry zone.

2026-07-17 tape check: The slide has continued. LITE $732.82, RSI 43 (down from 47.3), now -7.4% below SMA20 ($791.57) and -15.7% below SMA50 ($869.37). 7D -8.63%, 30D -13.79% (deepened further), 3M -18.13% (worse than -7.94%). -32.5% from 52wk high (widened from -26.13%) — the deepest drawdown in this file's history. Still above SMA200 (+28.1%, golden cross intact). None of the fundamental story has changed (still sold out through 2028); this reads as continued AI-capex-linked de-rating for the optical cohort rather than a name-specific break. No new fundamentals re-researched.

2026-07-25 tape check (Friday 2026-07-24 close): A real bounce has arrived. LITE $762.99 (+4.1% vs $732.82), RSI 46 (up from 43) — now only -2.1% below SMA20 (narrowed sharply from -7.4%) and -10.7% below SMA50 (narrowed from -15.7%). 7D has flipped positive to +4.12% (from -8.63%), 30D has improved to -9.44% (from -13.79%), and 3M has improved to -13.46% (from -18.13%). -23.21% from 52wk high — narrowed materially from -32.5%, the deepest drawdown this file had tracked. Still well above SMA200 (+29.7%, golden cross intact). Price is back inside the $700-$780 entry zone, near its upper edge. None of the fundamental story has changed (still sold out through 2028); no new fundamentals re-researched — this reads as stabilization after the deepest drawdown in this file's history.

2026-07-28 tape check: The stabilization has broken decisively. LITE $651.93 (-14.6% vs $762.99), including a -8.43% single-day move, RSI 37.5 (down from 46) — back to -14.7% below SMA20 (from -2.1%) and -22.5% below SMA50 (from -10.7%), both gaps wider than any prior checkpoint. 7D has reversed sharply to -22.16% (from +4.12%), 30D has deepened to -23.43% (from -9.44%), and 3M has deepened to -24.05% (from -13.46%). -39.95% from 52wk high — a new deepest drawdown for this file, surpassing the prior -32.5% record. Still above SMA200 (+9.9%, golden cross intact) — the long-term structure has not broken, though the cushion has narrowed sharply. No news identified in this data attributing the move; none of the sold-out-through-2028 fundamentals have been re-researched this cycle — this reads as the optical cohort's pullback resuming hard, not a resolved thesis break.

---

The Story Right Now

LITE is in the middle of the most violent re-rating in the optical networking space. The 12M run has been spectacular. As of 2026-06-16: price $875.36, RSI 47.9. The 7D bounce of +10.91% is a meaningful reversal from the weakness seen on May 29 ($854.96, -8.94% 7D). The 30D of -1.09% shows the stock has largely digested the prior pullback. The 3M of +34.76% confirms the medium-term thesis is intact. Price remains -3.2% below SMA20 ($904.67) — a close above would confirm the next leg.

Compared to the May 29 deep dive ($854.96, RSI 44.9, -8.94% 7D, -5.25% 30D), this is a material improvement. The stock is recovering from its oversold dip and the prior entry zone of $750-$850 has served as strong support.

What makes LITE unique among its peers: monopoly positioning. Bank of America estimates 50%+ global market share in high-speed EML (electroabsorption modulated lasers). These are the lasers inside every 800G and 1.6T transceiver. There is no alternative supply chain that comes close. When NVIDIA needed to ensure its Rubin-era GPUs wouldn't be bottlenecked by optics, it put $2B in non-cancelable purchase agreements specifically with Lumentum — alongside $2B each to Coherent and Marvell ($6B total across the optical stack).

The supply constraint is real: LITE expanded its Tokyo factory capacity by 12x and CEO Alan Lowe says it's still not enough. Sold-out window extended from end-of-2027 to ALL of 2028. New capex guidance $100M-$250M, scouting additional factory sites in Japan. They also acquired an InP (indium phosphide) optical device factory — vertical integration into the scarce substrate material that makes these lasers work. Plus a new 240,000 sq ft facility in Greensboro, NC for US manufacturing.

The risk? At elevated multiples, any demand deceleration gets punished hard. And the entire thesis depends on AI capex continuing to ramp. If hyperscalers cut spending, the sold-out window shrinks fast. But right now, every data point says demand is accelerating, not decelerating.

---

Quick Snapshot

---

Action Matrix

---

Price Data

---

Company Overview

One-Liner

The monopoly laser maker powering AI optical interconnects — 50%+ global EML market share, sold out through 2028.

Business Model

Key Segments

Geographic Mix

---

Competitive Analysis

Industry Position

Competitive Moat

Moat Assessment

Moat Width: Wide Moat Trend: Widening — InP acquisition + new factories deepen manufacturing advantage

Summary:

LITE's moat is the rarest kind in tech: physics-based manufacturing monopoly. EML lasers require specialized epitaxial growth, packaging, and testing that takes years to develop. The InP factory acquisition means LITE now controls its own substrate supply. No competitor can replicate this integrated capability in under 3-5 years, and by then the technology cycle may have moved to CPO (where LITE is also investing).

---

Management Assessment

Leadership

Capital Allocation

Red Flags

• Excessive exec compensation — not flagged
• High turnover in key roles — not flagged
• Related party transactions — not flagged
• Aggressive accounting — not flagged

---

Valuation

Current Multiples

Fair Value Assessment

At elevated multiples with sold-out capacity through 2028 and 40%+ revenue growth, LITE is not cheap but may be justified. The key question: can revenue growth sustain 30%+ for 3+ years? If AI capex continues ramping (and every hyperscaler says it will), the answer is likely yes.

Valuation risk: Extended above SMA200 means any negative surprise triggers a violent correction. The stock can be "right" on fundamentals and still drop 30-40% on a bad earnings print or guidance miss.

---

Bull Case

Why This Could Work

1. Monopoly bottleneck in AI's physical layer

   • Evidence: 50%+ EML share, no alternative supply chain, CEO confirms bottleneck status
   • Implication: Pricing power + demand visibility unlike any other AI play

2. NVDA $2B non-cancelable validates multi-year demand

   • Evidence: Through end of decade, covering Rubin-era GPU interconnects
   • Implication: Revenue floor is locked in, not speculative

3. Sold out through 2028 despite 12x capacity expansion

   • Evidence: Extended from 2027 to 2028, still scouting new factory sites
   • Implication: Demand growth is OUTPACING massive supply expansion

4. Four-wave technology roadmap gives longevity

   • Evidence: 800G (dominating) → LPO (ramping) → 1.6T (building) → CPO (investing)
   • Implication: Not a one-cycle play — each wave extends the growth runway

5. Vertical integration via InP acquisition

   • Evidence: Acquired indium phosphide optical device factory
   • Implication: Controls scarce substrate supply, deepens moat vs would-be competitors

Upside Scenario

---

Bear Case

What Could Go Wrong

1. AI capex cycle peaks

   • How it plays out: Hyperscalers cut spending, "sold out" becomes "overcapacity" in 12-18 months
   • Probability: Low (next 12 months) / Medium (2028+)

2. Valuation compression on growth deceleration

   • How it plays out: Revenue growth slows from 40%+ to 20%, multiple compresses from 27x to 15x = 45% drawdown
   • Probability: Medium (inevitable eventually, question is when)

3. Competition catches up

   • How it plays out: Broadcom or a Chinese player develops competitive EML, LITE loses pricing power
   • Probability: Low (3-5 year timeline for fab qualification)

4. Technology skip — direct to CPO

   • How it plays out: If CPO arrives faster than expected, 800G/1.6T discrete transceivers get bypassed
   • Probability: Low (CPO is 2028+ at earliest, LITE is investing in it too)

Thesis Killers

• NVDA or major hyperscaler cancels/reduces optical interconnect orders
• A competitor announces volume EML production (watch Broadcom, Chinese fabs)
• AI capex guidance cuts from 2+ hyperscalers in same quarter

Downside Scenario

---

Market-Moving News

Recent News

News Patterns

LITE moves on capacity announcements and customer commitments. The stock re-rates on every "sold out through [extended date]" headline. Pullbacks tend to come from broad tech selloffs, not LITE-specific bad news. The OFC conference (annual optical conference) is a reliable catalyst.

---

Related Markets & ETFs

Peer 30D figures refreshed 2026-08-08 (as of the 2026-08-07 close); prior snapshot (07-31 and earlier) showed the whole cohort pulling back together — that has since reversed for most of the group.

Sector Context

The optical supply chain re-rated dramatically on AI demand through mid-2026. As of 2026-07-11 LITE's own tape has pulled back hard (3M -7.94%, -26.13% off the 52-week high) — worth checking whether peers (COHR, CIEN, FN) are pulling back in sympathy or LITE is underperforming the group before reading too much into it.

---

Cross-References (Where This Appears in Our System)

---

Related Tickers to Monitor

---

Catalysts & Timing

Upcoming Catalysts

---

Entry Strategy

Position Sizing

My conviction: High Target allocation: 5-7%

Entry Approach

Technical Levels

---

The Gold

Key Discoveries

Open Questions

• What is the actual PE on forward earnings? 27x trailing vs forward matters
• How much of the $2B NVDA deal is in the current run-rate vs backlog?
• What's LITE's CPO roadmap? If they lead in Wave 4 too, the story extends to 2030+
• Is the Japanese yen a tailwind or risk for Tokyo factory economics?
• What happens to EML demand if CPO adoption accelerates past current timeline?
• Is the July pullback LITE-specific or a sector-wide (COHR/CIEN/FN) rotation out of optical names?

Key Changes vs 2026-07-28

Research Log

---

Sources